Skip to main content

Table 1 Patient demographics and mutations

From: The administration of antisense oligonucleotide golodirsen reduces pathological regeneration in patients with Duchenne muscular dystrophy

Characteristics

All patients (N = 25)

Age (years)

8.2 (2.2)

Height (cm)

120.1 (10.4)

Weight (kg)

28.2 (9.1)

BMI (kg/m2)

19.1 (3.7)

6MWT distance (m)

403.7 (56.7)

Time since DMD diagnosis (MO)

55.2 (24.9)

Duration of corticosteroid use (MO)

36.8 (25.9)

Patient Id

Mutation

1

∆49–52

2

∆45–52

3

∆45–52

4

∆45–52

5

∆49–52

6

∆48–52

7

∆48–52

8

∆45–52

9

∆48–52

10

∆50–52

11

∆50–52

12

∆49–52

13

∆45–52

14

∆45–52

15

∆49–52

16

∆52

17

∆50–52

18

∆45–52

19

∆45–52

20

∆48–52

21

∆49–52

22

∆50–52

23

∆48–52

24

∆52

25

∆52

  1. 6MWT 6-minute walk test, BMI body mass index, DMD Duchenne muscular dystrophy
  2. Values are shown as mean (SD)
  3. ∆ deletion of exons